Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in
The actual location of this job is in Stein, AG, Switzerland. Relocation assistance is available for eligible candidates and their families, if needed. Be part of a dynamic, fast-paced project environment where no two days are
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Who We Are: At Neurocrine Biosciences, we pride ourselves on having a strong, inclusive, and positive culture based on our shared purpose and values. We know what it takes to be great, and we are as
In 2024, Swissport International AG provided best‑in‑class airport ground services for some 247 million airline passengers (2023: 232 million) and handled roughly 5 million tons of air freight (2023: 4.7 million) at 117 air cargo centers worldwide. Several of its
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Executive Director, Regulatory Strategy page is loaded# Executive Director, Regulatory Strategyremote type: Hybridlocations: CH Allschwiltime type: Full timeposted on: Posted Todayjob requisition id: R6763# Who We Are:At Neurocrine Biosciences, we pride ourselves on having a strong,
Revolution Medicines is seeking a Director, Regulatory Affairs, Europe to lead regulatory strategy and execution for EU/EEA/UK/Switzerland oncology programs. You will drive MAA filings, lifecycle management, and proactive engagement with EMA, MHRA and Swissmedic, guiding cross‑functional teams
Summary of Position Scholar Rock is seeking an experienced and motivated Senior Director, Commercial Quality / Market Quality (Switzerland) to build and lead a phase‑appropriate, scalable, and inspection‑ready Commercial Quality function as Scholar Rock advances to
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‐addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Skilled Recruitment Solutions GmbH seeks a Senior Manager, GCP Inspection Lead to join a fast-paced biopharmaceutical environment in Basel. You will own frontline defense and preparation for global health authority audits, reporting to the Senior Director
Are you a seasoned GCP Quality Assurance expert who thrives when leading high-stakes health authority inspections? Do you possess the diplomacy, resilience, and operational sharpness to step directly into a fast-paced, live-inspection environment? We are partnering